Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic

The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Revasc Med
Autors principals: Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Chezar-Azerrad, Chava, Hashim, Hayder, Ben-Dor, Itsik, Satler, Lowell F., Mintz, Gary S., Waksman, Ron
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2020
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://ncbi.nlm.nih.gov/pubmed/32471712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.carrev.2020.05.027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars